Raíssa Nóbrega de Almeida
Biographic Data
| ID | 7957439 |
|---|---|
| NAME | Raíssa Nóbrega de Almeida |
| GIVEN NAMES | Raíssa Nóbrega |
| FAMILY NAME | de Almeida |
| SIGNATURE | DE ALMEIDA R N |
| AFFILIATIONS | Universidade Federal do Rio Grande do Norte |
| ORCID | 0000-0003-3687-8790 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2018 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Use of sleep quality questionary and cortisol awakening response as complementary tools for the evaluation of major depression progression
Psychophysiological responses to group cognitive-behavioral therapy in depressive patients
Moderators of ayahuasca’s biological antidepressant action
In summary, some specific emotional and physiological parameters during experimental ayahuasca session were revealed as critical moderators of the improvement of major depression biomarkers, mainly BDNF and SC two days after ayahuasca intake. These findings contribute to paving the way for future studies investigating the biological antidepressant response to psychedelic therapy
Cortisol Modulation by Ayahuasca in Patients With Treatment Resistant Depression and Healthy Controls
Major depression is a highly prevalent mood disorder, affecting about 350 million people, and around 30% of the patients are resistant to currently available antidepressant medications. Recent evidence from a randomized controlled trial supports the rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression. The aim of this study was to explore the effect of ayahuasca on plasma cortisol and awakening salivary cort…
No prominent works on this page.
Cortisol Modulation by Ayahuasca in Patients With Treatment Resistant Depression and Healthy Controls
Major depression is a highly prevalent mood disorder, affecting about 350 million people, and around 30% of the patients are resistant to currently available antidepressant medications. Recent evidence from a randomized controlled trial supports the rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression. The aim of this study was to explore the effect of ayahuasca on plasma cortisol and awakening salivary cort…
Moderators of ayahuasca’s biological antidepressant action
In summary, some specific emotional and physiological parameters during experimental ayahuasca session were revealed as critical moderators of the improvement of major depression biomarkers, mainly BDNF and SC two days after ayahuasca intake. These findings contribute to paving the way for future studies investigating the biological antidepressant response to psychedelic therapy
Psychophysiological responses to group cognitive-behavioral therapy in depressive patients
Use of sleep quality questionary and cortisol awakening response as complementary tools for the evaluation of major depression progression
Psychology (4 works) · Clinical Psychology (3 works) · Major depressive disorder (3 works) · Medicine (3 works) · Psychiatry (3 works) · Antidepressant (2 works) · Anxiety (2 works) · Ayahuasca (2 works) · Biochemical Analysis and Sensing Techniques (2 works) · Internal Medicine (2 works)